Borosil Scientific Share Price Target 2027: Is Rs 134 Realistic? Bull Case Points to Rs 161
- November 19, 2026
- Posted by: Chaitanya Auti
- Category: Market
Borosil Scientific share price Rs 110.97 (19 November 2026). Base target Rs 134, bull Rs 161, downside risk Rs 89.5. PE 21.81. 52W range Rs 96.64 to Rs 180.80.
Quick Answer
The Borosil Scientific share price target for 2027 is Rs 134, about 20.8% above the current price of Rs 110.97. The bull case is Rs 161, and the downside risk level, which is not a target, is Rs 89.5. The base case assumes earnings per share grow 20.0% a year, a cap applied because the FY24 to FY26 pace was 21.2%, with the stock holding its PE of 21.81. These are model-based estimates built from reported financials, not guaranteed outcomes.
Investors weighing a Borosil Scientific target price for 2027 should start with where the stock sits today. At Rs 110.97 on 19 November 2026, it is 38.6% below its 52-week high of Rs 180.80 and 14.8% above its 52-week low of Rs 96.64. That range spans 87% from low to high, so the entry point matters as much as the Borosil Scientific price forecast itself.
This article builds the Borosil Scientific share price target from reported numbers only: three years of annual results, the last five quarters, the latest shareholding pattern and current valuation ratios from company filings and exchange data. Each scenario states its assumptions, so you can trace how the base case, the bull case and the downside risk level were reached and test them against your own view.
Click Here – Get Free Investment Predictions
Borosil Scientific Stock Analysis: Company Overview and Key Stats
Borosil Scientific (NSE: BOROSCI) has a market capitalisation of Rs 995.00 crore. In FY26 it reported revenue of Rs 476.89 crore and net profit of Rs 34.58 crore. The table collects the figures the Borosil Scientific share price target is built on.
| Metric | Value |
|---|---|
| Company | Borosil Scientific |
| NSE Ticker | BOROSCI |
| CMP (19 November 2026) | Rs 110.97 |
| 52-Week High | Rs 180.80 |
| 52-Week Low | Rs 96.64 |
| Market Cap | Rs 995.00 crore |
| PE Ratio (TTM) | 21.81 |
| Industry PE | 36.03 |
| Price to Book | 2.20 |
| Return on Equity | 10.09% |
| Debt to Equity | 0.01 |
| EPS (TTM) | Rs 5.13 |
| Dividend Yield | 0.00% |
| 12-Month Base Target | Rs 134 |
| Bull Case | Rs 161 |
| Downside Risk Level (not a target) | Rs 89.5 |
Why Is Borosil Scientific Share Price Target Set at Rs 134 for 2027?
The arithmetic is short. Trailing EPS of Rs 5.13 grown for one year gives a forward EPS estimate of Rs 6.16, and multiplying it by the unchanged PE of 21.81 gives the Rs 134 base-case Borosil Scientific stock target. The bull case adds faster earnings growth and a higher multiple, while the downside risk level assumes flat earnings and a lower multiple.
Earnings Growth Behind the Borosil Scientific Target Price: Three Years of Results
Borosil Scientific grew revenue from Rs 400.00 crore in FY24 to Rs 476.89 crore in FY26, a compound annual growth rate of 9.2%. Net profit grew faster, from Rs 23.48 crore to Rs 34.58 crore (21.4% a year), which shows margin gains did part of the work and not just higher sales.
| Financial Year | Revenue (Rs Cr) | Net Profit (Rs Cr) | EPS (Rs) | Dividend per Share (Rs) |
|---|---|---|---|---|
| FY24 | 400.00 | 23.48 | 2.65 | 0.00 |
| FY25 | 446.30 | 26.72 | 3.02 | 0.00 |
| FY26 | 476.89 | 34.58 | 3.89 | 0.00 |
FY26 revenue growth was 6.9%, slower than the two-year average of 9.2%, and net profit moved up 29.4%. EPS rose from Rs 2.65 in FY24 to Rs 3.89 in FY26. The FY27 outlook for the Borosil Scientific price target depends on whether that EPS estimate keeps compounding.
Margins and the Latest Quarter
Borosil Scientific converted 7.3% of FY26 revenue into net profit, against 6.0% in FY25, within a three-year range of 5.9% to 7.3%. EBITDA margin was 13.3% in FY26 versus 13.5% in FY25.
In the September 2026 quarter, revenue was Rs 117.37 crore, up 7.6% from the same quarter a year earlier, while net profit of Rs 5.31 crore was up 86.3%. EBITDA came in at Rs 13.11 crore, up 28.9% year on year. The next quarterly result is the first test of whether the earnings assumption behind the Borosil Scientific stock target holds.
Balance Sheet and Cash Flow
Debt to equity stands at 0.01, and shareholders’ equity grew from Rs 376.20 crore in FY24 to Rs 441.49 crore in FY26. Operating cash flow in FY26 was Rs 43.27 crore against capital expenditure of Rs 28.45 crore, leaving free cash flow of Rs 14.82 crore, or 1.5% of the current market capitalisation. In FY25 free cash flow was Rs 105.87 crore.
Valuation Check for the Borosil Scientific Stock Target: PE, Price to Book and ROE
At a PE of 21.81 against an industry PE of 36.03, Borosil Scientific trades at a discount to its industry. Price to book is 2.20 on a book value of Rs 50.77 per share, and return on equity is 10.09%. A PE of 21.81 equals an earnings yield of 4.6%, and the FY26 dividend of Rs 0.00 per share gives a yield of 0.00%.
Shareholding Pattern and Institutional Holding
Promoters held 68.27% of Borosil Scientific in September 2026, and promoter holding rose from 67.81% in September 2025 to 68.27% in September 2026. Foreign institutional investors (FII) held 0.14% and domestic institutions (DII) held 0.28%, which puts total institutional holding at 0.42%. FII holding has stayed near 0.14% since September 2025. Public shareholders own the remaining 31.31%. Institutional holding this low means the stock sees limited professional coverage, and price moves can be sharper when trading volumes are thin.
Borosil Scientific Share Price Targets for the Short Term and 12 Months
Short Term Borosil Scientific Stock Target Levels: Technical Setup
At Rs 110.97 on 19 November 2026, Borosil Scientific trades below its 50-day simple moving average of Rs 112.45 and below its 200-day exponential moving average of Rs 126.22. The 14-day RSI reads 68.0, which is neutral territory, and the MACD line sits above its signal line. The nearest resistance level is Rs 112.45 (50-day simple moving average) and the nearest support is Rs 96.64 (52-week low). A sustained move above Rs 112.45 would improve the short-term setup, while a close below Rs 96.64 would shift attention to the next support.
12 Month Borosil Scientific Target Price for 2027
The 12-month target of Rs 134 means a move of 20.8% up from Rs 110.97 over the next 12 months. It would still leave the stock 25.9% below its 52-week high of Rs 180.80. Anyone checking the Borosil Scientific share price target against their own view should focus on two inputs: the EPS estimate and the PE multiple.
How EPS Growth and PE Multiple Change the Borosil Scientific Target Price
| EPS Growth | PE 17.45 | PE 21.81 | PE 25.08 |
|---|---|---|---|
| 0.0% (EPS Rs 5.13) | Rs 89.5 | Rs 112 | Rs 129 |
| 20.0% (EPS Rs 6.16) | Rs 107 | Rs 134 | Rs 154 |
| 25.0% (EPS Rs 6.41) | Rs 112 | Rs 140 | Rs 161 |
Each cell multiplies the forward EPS estimate by the PE shown. Reading across a row shows what a de-rating or re-rating does to the Borosil Scientific price forecast, and reading down a column shows what earnings growth is worth at a fixed multiple.
Bull Case and Downside Risk for Borosil Scientific Stock Target in 2027
Bull Case Rs 161
The bull case Borosil Scientific price target needs EPS growth of 25.0%, which lifts forward EPS to Rs 6.41, and a PE multiple that rises 15% to 25.08. That gives Rs 161, 45.1% above the current price and below the 52-week high of Rs 180.80.
Downside Risk Level Rs 89.5
The downside risk level is not a target. It assumes EPS stays flat at Rs 5.13 and the PE falls 20% to 17.45. That gives Rs 89.5, 19.3% below the current price and below the 52-week low of Rs 96.64.
| Scenario | EPS Growth | PE Multiple | Price (Rs) | Change vs CMP |
|---|---|---|---|---|
| Bull Case | 25.0% | 25.08 | Rs 161 | +45.1% |
| Base Case | 20.0% | 21.81 | Rs 134 | +20.8% |
| Downside Risk | 0.0% | 17.45 | Rs 89.5 | -19.3% |
Key Risks to the Borosil Scientific Target Price for 2027
Growth Slowdown Risk for the Borosil Scientific Price Target
Revenue in the September 2026 quarter was up 7.6% year on year, and FY26 revenue growth was 6.9%. If growth slows from here, the EPS estimate behind the Borosil Scientific stock target will need revising.
Liquidity and Size Risk
Borosil Scientific has a market capitalisation of Rs 995.00 crore. Institutional holding is 0.42%, and promoters hold 68.27%. Stocks of this size can move sharply on small volumes, and exits can take longer than entries.
Valuation and Margin Risk
Net margin was 7.3% in FY26, so a small slip in costs moves profit noticeably. At a PE of 21.81 versus an industry PE of 36.03, a de-rating toward the downside-risk PE of 17.45 would cut the price even if earnings hold.
Market and Technical Risk
Technical indicators add short-term risk: the 14-day RSI is 68.0 and the MACD sits above its signal line. A broad fall in the Nifty 50 or the Sensex can override company fundamentals for weeks at a time.
How to Invest in Borosil Scientific
Start with the live price and volume. Any Borosil Scientific share price target is only as current as the data behind it, and the data here is as of 19 November 2026, so refresh the Rs 110.97 price before acting on any level.
Next, review the fundamentals yourself. The Univest Screener lets you check Borosil Scientific’s PE, ROE, debt and shareholding in one place.
Check Borosil Scientific fundamentals on the Univest Screener
Then compare the three Borosil Scientific target price scenarios with your own view. If you expect EPS growth below 20.0%, the base case is too optimistic for you; if you expect more, the bull case deserves weight.
Decide your position size and exit levels before you buy. The support and resistance levels above can serve as reference points, but they are not recommendations.
Finally, place the order through a SEBI-registered broker or the Univest app, and review the position after each quarterly result. Consult a SEBI-registered advisor if you are unsure.
Download the Univest iOS App or Univest Android App to track Borosil Scientific live price and get daily stock recommendations.
Conclusion
The Borosil Scientific share price target for 2027 is Rs 134 in the base case, with Rs 161 as the bull case. The support for that view is arithmetic you can check: EPS grew 21.2% a year over FY24 to FY26, and the stock trades at a PE of 21.81. The risks are equally concrete, including a net margin of just 7.3% that leaves profit sensitive to costs and a downside scenario that cuts the price 19% if earnings stall. Use these numbers as a framework for judging the Borosil Scientific price target, check them against the latest filings, and size any position to your own risk appetite.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Borosil Scientific Share Price Target 2027
What is the Borosil Scientific share price target for 2027?
Ans. The base-case Borosil Scientific share price target for 2027 is Rs 134, which is 20.8% above the price of Rs 110.97 on 19 November 2026. The bull case is Rs 161 and the downside risk level, which is not a target, is Rs 89.5. All three come from one method: forward EPS multiplied by a PE multiple, using only reported results. They are model estimates and not guaranteed outcomes, and the next quarterly result is the first check on the EPS assumption.
What is the Borosil Scientific share price today?
Ans. As of 19 November 2026, 9:27 AM IST, Borosil Scientific (NSE: BOROSCI) trades at Rs 110.97, down 0.62% on the day. That is 38.6% below the 52-week high of Rs 180.80 and 14.8% above the 52-week low of Rs 96.64. The market capitalisation of Rs 995.00 crore places it among small-cap stocks. Prices change through the trading session, so check the live quote before acting on any level in this article.
Is Borosil Scientific a buy or sell at the current price?
Ans. The data points both ways. On the positive side, EPS has grown 21.2% a year over FY24 to FY26 and the base case implies 20.8% upside; on the cautious side, the net margin is a thin 7.3%, and the downside risk level of Rs 89.5 is 19% below the current price. Whether Borosil Scientific fits your portfolio depends on your time horizon, position size and risk appetite. Consult a SEBI-registered advisor before investing, as this article is not investment advice.
What are the bull case target and downside risk level for Borosil Scientific shares?
Ans. The bull case in the Borosil Scientific share price target for 2027 is Rs 161, which assumes 25.0% EPS growth and a PE of 25.08, a 15% re-rating from today’s multiple. That is 45.1% above the current price and below the 52-week high of Rs 180.80. The downside risk level is Rs 89.5, which assumes flat EPS and a PE of 17.45, 20% lower than today. It sits 19.3% below the current price and below the 52-week low of Rs 96.64, and it marks a risk to watch, not a target.
What are the main risks to the Borosil Scientific price target?
Ans. Four risks matter most for the Borosil Scientific share price target: slower revenue or profit growth, a PE de-rating, thin liquidity or size risk, and weakness in the broader market. With a market capitalisation of Rs 995.00 crore, the stock can move sharply on small volumes, and exits can take longer than entries. A fall to the downside-risk PE of 17.45 would cut the price even if earnings hold.
What is the PE ratio of Borosil Scientific and how does it compare with the industry?
Ans. The PE ratio of Borosil Scientific is 21.81, against an industry PE of 36.03, which is a discount to the industry. Price to book is 2.20 and return on equity is 10.09%, and the PE equals an earnings yield of 4.6%. The base case holds the PE unchanged, so the Borosil Scientific share price target moves only with earnings, while the bull and downside scenarios change the multiple by +15% and -20%.
Who owns Borosil Scientific, and what is the promoter holding?
Ans. Promoters held 68.27% of Borosil Scientific in September 2026. FII held 0.14%, DII held 0.28% and the public held 31.31%. Together the two institutional groups hold 0.42%. Shareholding is filed every quarter, so it is worth rechecking after each result.
What were Borosil Scientific’s latest quarterly results?
Ans. In the September 2026 quarter, Borosil Scientific reported revenue of Rs 117.37 crore (up 7.6% year on year) and net profit of Rs 5.31 crore (up 86.3%). For comparison, FY26 full-year revenue growth was 6.9% and net profit moved up 29.4%. Each new quarter either supports or weakens the EPS growth of 20.0% assumed in the base case.